24 MARCH 2023 | VP TEAM RUAIRI ABRAHAMS, BOIKHUTSO NTSOKO, ROXANNE HARRIS AND ROZANNE ENGEL. VIDEOGRAPHY RUAIRI ABRAHAMS AND BOIKHUTSO NTSOKO. VIDEO EDIT RUAIRI ABRAHAMS. PHOTO LERATO MADUNA.
On World TB Day, the University of Cape Town (UCT) shines the spotlight on phase three of a clinical trial led by clinicians at the South African Tuberculosis Vaccine Initiative (SATVI).
The study aims to explore and assess the safety, immunogenicity and efficacy of the novel MTBVAC as a potential TB vaccine alternative to the age-old bacille Calmette-Guerin (BCG), currently administered at birth to protect babies from TB.